Reasons to avoid automatic substitution Head-to-head data are limited
Emerging treatments are targeting multiple metabolic pathways simultaneously to deliver superior weight loss outcomes and improved patient adherence
It sounded almost too good to be trueand in many ways, it was
Some benefits of FDA-approved GLP-1/GIP medications beyond weight loss are supported by emerging research and may vary based on individual health conditions, including: Improve blood sugar regulation, increase insulin sensitivity, and lower A1C Reduce long-term diabetic risks and protect pancreatic function Lower cholesterol, triglycerides, and blood pressure, supporting long-term cardiovascular health Show promising reductions in heart attacks and strokes in early studies Reduce liver fat and potentially improve metabolic fatty liver disease
If you want to explore whether tirzepatide suits your body's metabolic genetics before committing, PlexusDx offers a no-membership monthly structure that lets you pause or switch medications easily
Track your intake during the first few weeks to establish a baseline